FDA clears Verily’s Study Watch for ECG
The FDA-approved Study Watch is a prescription-only device aimed to record, store, transfer and display single-channel ECG rhythms. It is suggested for use by healthcare professionals, adult patients
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XThe FDA-approved Study Watch is a prescription-only device aimed to record, store, transfer and display single-channel ECG rhythms. It is suggested for use by healthcare professionals, adult patients
Erada, which was founded by Benji Pretorius and Richard Schmidt, is situated in Musina, South Africa. The alliance will market the test as a Saliva-based Malaria Asymptomatic and
Including these new patents and notices, the Company has 28 issued patents and 70 pending patent applications in the U.S., Europe, Canada, Australia, Japan and China. With respect
The partnership between Garmin International and ActiGraph will explore the creation of new health and activity monitoring solutions. The solutions will leverage Garmin wearables and ActiGraph‘s CentrePoint data
The data presented by the company reinforces the durability, safety, and effectiveness of the IN.PACT Admiral drug-coated balloon in patients with peripheral artery disease (PAD) in the superficial
Pulse Biosciences said the feasibility study will include up to 20 subjects at the Scripps Clinic in San Diego, California, US. Eligible subjects receive NPS treatment(s) followed by
Based in Wurmlingen, Germany, Emerging Implant Technologies (EIT) is a privately held manufacturer of 3D-printed titanium interbody implants for spinal fusion surgery. The company is claimed to be
Earlier, only patients over 10 kilograms were eligible for RAM sensors, but wit the new clearance acoustic respiration rate measurement is now possible for patients of all sizes,
The new version, which will be showcased at the 30th European Congress of Pathology (ECP) 2018, from 8-12 September at Euskalduna Conference Centre, leverages deep learning AI to
The treatment, delivered via the EyeGate II drug delivery system, showed clinical efficacy in reducing anterior chamber cell score but did not demonstrate non-inferiority to a prednisolone acetate